비교리스트

 카트 문의
시장보고서
상품코드
1543928

세계의 골수내 주입 기기 시장

Intraosseous Infusion Devices
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 194 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 골수내 주입 기기 시장은 2030년까지 82억 달러에 도달

2023년에 54억 달러로 추정되는 세계의 골수내 주입 기기 시장은 2023-2030년 CAGR 6.3%로 성장하며, 2030년에는 82억 달러에 달할 것으로 예측됩니다. 본 리포트에서 분석한 부문의 하나인 자동 기술은 CAGR 7.5%를 기록하며, 분석 기간 종료시에는 56억 달러에 달할 것으로 예측됩니다. 수동 기술 부문의 성장률은 분석 기간 중 CAGR 4.3%로 추정됩니다.

미국 시장은 15억 달러로 추정, 중국은 CAGR 5.8%로 성장 예측

미국의 골수내 주입 기기 시장은 2023년에 15억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 13억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2023-2030년 CAGR은 5.8%입니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 6.1%와 4.9%로 예측됩니다. 유럽에서는 독일이 CAGR 5.0%로 성장할 것으로 예측됩니다.

세계의 골수내 주입 기기 시장 - 주요 동향과 촉진요인 정리

골수내 주입 기기란 무엇이며, 왜 구급 의료에 필수적인가?

골수내 주입 기기는 기존 정맥내(IV) 액세스가 불가능한 경우에 수액, 약물 및 혈액 제제를 골수에 직접 투여할 수 있도록 고안된 특수 의료기기입니다. 이 장비는 특히 외상, 심장마비, 쇼크와 같은 위급한 상황에서 정맥이 막혔거나 정맥에 접근하기 어려운 다른 상태에 처한 환자들에게 중요한 역할을 합니다. 정맥주입은 신속하고 신뢰할 수 있으며 효과적인 정맥 접근을 위한 대안을 제공하여 생명을 구할 수 있는 치료를 신속하게 시행할 수 있도록 합니다. 이러한 장비의 사용은 특히 응급실, 중환자실, 군 등 즉각적인 혈관 접근이 환자 결과에 큰 영향을 미치는 상황에서 증가하고 있습니다.

기술의 발전은 골수내 주입 기기 시장을 어떻게 형성하고 있는가?

기술의 발전은 골수내 주입 기기 시장 형성에 중요한 역할을 하고 있으며, 특히 기기의 디자인, 사용 편의성 및 안전 기능의 혁신이 중요합니다. 최신 골내 삽입 기구는 점점 더 자동 또는 반자동으로 도입되도록 설계되어 삽입에 필요한 숙련도를 줄이고 합병증 위험을 최소화합니다. 이러한 기구들은 바늘에 찔리는 손상을 방지하고 골수 내에 안정적으로 고정될 수 있도록 안전장비를 갖추고 있는 경우가 많습니다. 또한 재료 및 엔지니어링의 발전으로 인해 응급 상황에서 가혹한 사용에도 견딜 수 있는 더 튼튼하고 신뢰할 수 있는 기기가 개발되고 있습니다. 이러한 기술 혁신으로 골수내 주입은 더 많은 의료 서비스 프로바이더가 쉽게 이용할 수 있게 되었으며, 병원 전, 병원 및 군 환경에서 사용이 확대되고 있습니다.

골수내 주입 기기에 대한 헬스케어 현장 수요가 증가하는 이유는 무엇인가?

중환자 치료에서 골수내 주입 기기에 대한 수요가 증가하고 있으며, 의료 종사자 교육 프로그램이 확대됨에 따라 의료계 전반에서 골수내 주입 기기에 대한 수요가 증가하고 있습니다. 구급대원, 구급대원, 군의관 등 더 많은 의료진이 복강내 장비 사용에 대한 교육을 받고 있으므로 이 기기의 채택이 더욱 확산되고 있습니다. 이 기기는 응급실이나 중증 환자 이송 중과 같이 순환계로의 빠른 접근이 필수적인 상황에서 특히 유용하게 사용되고 있습니다. 또한 혈관 합병증을 유발할 수 있는 만성질환 및 질환의 확산으로 인해 대체 혈관 접근법의 필요성이 높아지면서 골수내 주입 기기에 대한 수요가 더욱 증가하고 있습니다. 이러한 장비의 채택은 특정 응급 상황에서 사용을 권장하는 최신 임상 지침과 프로토콜에 의해 지원되고 있으며, 현대 의료 현장에서의 역할이 강화되고 있습니다.

골수내 주입 기기 시장의 성장을 가속하는 요인은 무엇인가?

골수내 주입 기기 시장의 성장은 기술 발전, 용도 확대 및 중환자 치료에서 신속한 혈관 접근에 대한 요구 증가와 밀접한 관련이 있는 몇 가지 요인에 의해 주도되고 있습니다. 주요 촉진요인 중 하나는 장비 설계의 발전으로 인해 복강내 주입이 더 쉽고, 더 안전하고, 더 신뢰할 수 있게 되었습니다. 이로 인해 응급실, 중환자실, 병원 전 진료 등 다양한 의료 환경에서 채택이 확대되고 있습니다. 또한 외상, 심장 응급 상황 및 즉각적인 혈관 접근이 필요한 기타 질환의 발생률이 증가함에 따라 기존의 정맥 접근이 어려운 경우 빠르고 효과적인 대안을 제공하므로 시장 성장에 박차를 가하고 있습니다. 또한 응급상황에서 환자의 예후를 개선하는 데 대한 관심이 높아지고 의료 전문가를 위한 교육이 점점 더 많이 제공되고 있는 것도 시장 성장의 원동력이 되고 있습니다. 이러한 추세에 따라 골수내 주입 기기 시장은 첨단이고 신뢰할 수 있는 신속한 혈관 접근 솔루션에 대한 중환자 치료 현장의 요구에 힘입어 지속적인 성장이 예상되고 있습니다.

조사 대상 기업의 예(총 42건)

  • Aero Healthcare
  • Becton, Dickinson and Company
  • Biopsybell Srl
  • Cook Medical, Inc.
  • PAVmed, Inc.
  • PerSys Medical
  • Pyng Medical
  • Teleflex, Inc.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSA 24.09.03

Global Intraosseous Infusion Devices Market to Reach US$8.2 Billion by 2030

The global market for Intraosseous Infusion Devices estimated at US$5.4 Billion in the year 2023, is expected to reach US$8.2 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Automatic Technology, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$5.6 Billion by the end of the analysis period. Growth in the Manual Technology segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 5.8% CAGR

The Intraosseous Infusion Devices market in the U.S. is estimated at US$1.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 5.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.1% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Intraosseous Infusion Devices Market - Key Trends & Drivers Summarized

What Are Intraosseous Infusion Devices and Why Are They Critical in Emergency Medical Care?

Intraosseous infusion devices are specialized medical tools designed to deliver fluids, medications, and blood products directly into the bone marrow when traditional intravenous (IV) access is not feasible. These devices are critical in emergency medical care, particularly in situations where time is of the essence, such as during trauma, cardiac arrest, or shock, where patients may have collapsed veins or other conditions that make IV access difficult. Intraosseous infusion provides a rapid, reliable, and effective alternative for vascular access, ensuring that lifesaving treatments can be administered quickly. The use of these devices is growing, especially in emergency rooms, intensive care units, and military settings, where immediate vascular access can significantly impact patient outcomes.

How Are Technological Advancements Shaping the Intraosseous Infusion Devices Market?

Technological advancements are playing a significant role in shaping the intraosseous infusion devices market, particularly through innovations in device design, ease of use, and safety features. Modern intraosseous devices are increasingly being designed for automatic or semi-automatic deployment, which reduces the skill level required for insertion and minimizes the risk of complications. These devices now often feature safety mechanisms to prevent needle-stick injuries and to ensure secure placement within the bone marrow. Additionally, advancements in materials and engineering have led to the development of more durable and reliable devices that can withstand the rigors of emergency use. These innovations are making intraosseous infusion more accessible to a broader range of healthcare providers, thereby expanding its use in pre-hospital, hospital, and military environments.

Why Is There an Increasing Demand for Intraosseous Infusion Devices Across Healthcare Settings?

The demand for intraosseous infusion devices is increasing across healthcare settings due to the growing recognition of their effectiveness in critical care situations and the expanding training programs for healthcare professionals. As more healthcare providers, including paramedics, emergency physicians, and military medics, are trained in the use of intraosseous devices, their adoption is becoming more widespread. The devices are particularly valued in settings where rapid access to the circulatory system is essential, such as in emergency rooms and during transport of critically ill patients. Additionally, the increasing prevalence of chronic diseases and conditions that can lead to vascular complications is driving the need for alternative vascular access methods, further boosting demand for intraosseous infusion devices. The adoption of these devices is also supported by updated clinical guidelines and protocols that recommend their use in specific emergency situations, reinforcing their role in modern medical practice.

What Factors Are Driving the Growth in the Intraosseous Infusion Devices Market?

The growth in the intraosseous infusion devices market is driven by several factors closely tied to technological advancements, expanding applications, and the increasing need for rapid vascular access in critical care. One of the primary drivers is the advancement in device design, which has made intraosseous infusion easier to perform, safer, and more reliable. This has led to broader adoption across various healthcare settings, including emergency departments, intensive care units, and pre-hospital care. The rising incidence of trauma, cardiac emergencies, and other conditions requiring immediate vascular access is also fueling market growth, as these devices offer a fast and effective alternative when traditional IV access is challenging. Additionally, the growing focus on improving patient outcomes in emergency situations, along with the increasing availability of training for healthcare professionals, is driving the market forward. As these trends continue to evolve, the intraosseous infusion devices market is expected to experience sustained growth, driven by the need for advanced, reliable, and rapid vascular access solutions in critical care scenarios.

Select Competitors (Total 42 Featured) -

  • Aero Healthcare
  • Becton, Dickinson and Company
  • Biopsybell Srl
  • Cook Medical, Inc.
  • PAVmed, Inc.
  • PerSys Medical
  • Pyng Medical
  • Teleflex, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Intraosseous Infusion Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Rapid Access in Emergency Medicine Spurs Adoption of Intraosseous Infusion Devices
    • Advancements in Device Technology Propel Innovation in Intraosseous Infusion
    • Shift Towards Minimally Invasive Emergency Procedures Expands Market Opportunities
    • Increasing Adoption of Intraosseous Infusion in Pediatric and Geriatric Patients
    • Role of Intraosseous Devices in Military and Disaster Medicine
    • Growing Importance of Immediate Vascular Access in Critical Care
    • Expansion of Pre-Hospital Care Drives Demand for Portable Intraosseous Devices
    • Emerging Markets Present New Opportunities for Intraosseous Device Manufacturers
    • Push for Cost-Effective and Easy-to-Use Infusion Solutions
    • Role of Intraosseous Devices in Enhancing Survival Rates in Trauma Cases
    • Integration of Intraosseous Infusion Devices with Advanced Monitoring Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Sternum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Sternum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Sternum by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Distal & Proximal Tibia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Distal & Proximal Tibia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Distal & Proximal Tibia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Distal Femur by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Distal Femur by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Distal Femur by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Calcaneus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Calcaneus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Calcaneus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Head of Humerus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Head of Humerus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Head of Humerus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Automatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Automatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Automatic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Manual by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Manual by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Manual by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for EMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for EMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for EMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Cardiac Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Cardiac Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Cardiac Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 34: World Intraosseous Infusion Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Intraosseous Infusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Intraosseous Infusion Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Intraosseous Infusion Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Intraosseous Infusion Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Intraosseous Infusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Intraosseous Infusion Devices by Route Of Administration - Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Intraosseous Infusion Devices by Route Of Administration - Percentage Breakdown of Value Sales for Sternum, Distal & Proximal Tibia, Distal Femur, Calcaneus and Head of Humerus for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by Technology - Automatic and Manual - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Intraosseous Infusion Devices by Technology - Automatic and Manual Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Intraosseous Infusion Devices by Technology - Percentage Breakdown of Value Sales for Automatic and Manual for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Intraosseous Infusion Devices by End-Use - EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Intraosseous Infusion Devices by End-Use - Percentage Breakdown of Value Sales for EMS, Hospitals, Ambulatory Surgery Centers and Cardiac Care Centers for the Years 2014, 2024 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제